[go: up one dir, main page]

NO20092655L - 2-quinolinone and 2-quinoxalinone derivatives and their use as antibacterial agents - Google Patents

2-quinolinone and 2-quinoxalinone derivatives and their use as antibacterial agents

Info

Publication number
NO20092655L
NO20092655L NO20092655A NO20092655A NO20092655L NO 20092655 L NO20092655 L NO 20092655L NO 20092655 A NO20092655 A NO 20092655A NO 20092655 A NO20092655 A NO 20092655A NO 20092655 L NO20092655 L NO 20092655L
Authority
NO
Norway
Prior art keywords
quinolinone
antibacterial agents
quinoxalinone derivatives
quinoxalinone
derivatives
Prior art date
Application number
NO20092655A
Other languages
Norwegian (no)
Inventor
Folkert Reck
Bolin Geng
Janelle Comita-Prevoir
Mark Cronin
Andrew Aydon Godfrey
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39046831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092655(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20092655L publication Critical patent/NO20092655L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Foreliggende oppfinnelse angår forbindelser med formel (I), og farmasøytisk akseptable salter derav, deres anvendelse ved behandling av bakterielle infeksjoner og deres fremgangsmåter for fremstilling.The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, to their use in treating bacterial infections and to their methods of preparation.

NO20092655A 2006-12-15 2009-07-13 2-quinolinone and 2-quinoxalinone derivatives and their use as antibacterial agents NO20092655L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87018106P 2006-12-15 2006-12-15
US96916307P 2007-08-30 2007-08-30
PCT/GB2007/004766 WO2008071961A1 (en) 2006-12-15 2007-12-13 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
NO20092655L true NO20092655L (en) 2009-09-02

Family

ID=39046831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092655A NO20092655L (en) 2006-12-15 2009-07-13 2-quinolinone and 2-quinoxalinone derivatives and their use as antibacterial agents

Country Status (17)

Country Link
EP (1) EP2121702A1 (en)
JP (1) JP2010513255A (en)
KR (1) KR20090090385A (en)
AR (1) AR064369A1 (en)
AU (1) AU2007331247B2 (en)
BR (1) BRPI0720236A2 (en)
CA (1) CA2671485A1 (en)
CL (1) CL2007003641A1 (en)
CO (1) CO6190619A2 (en)
EC (1) ECSP099506A (en)
MX (1) MX2009006325A (en)
NO (1) NO20092655L (en)
PE (1) PE20081511A1 (en)
RU (1) RU2009126731A (en)
TW (1) TW200831517A (en)
UY (1) UY30788A1 (en)
WO (1) WO2008071961A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (en) 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. Novel nitrogenated heterocyclic compound and salt thereof
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
WO2010041218A2 (en) 2008-10-10 2010-04-15 Actelion Pharmaceuticals Ltd Oxazolidinyl antibiotics
AR076222A1 (en) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US20130259899A1 (en) * 2010-10-04 2013-10-03 Allen-Vercoe, Emma Molecular And Cellular Biology University Of Guelph Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
SG11202001062XA (en) 2017-08-21 2020-03-30 Acadia Pharm Inc Compounds, salts thereof and methods for treatment of diseases
WO2019040104A2 (en) * 2017-08-21 2019-02-28 Acadia Pharmaceuticals Inc. Compounds, salts thereof and methods for treatment of diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601265A1 (en) * 1996-01-16 1997-07-17 Bayer Ag 2-oxo and 2-thio-1,2-dihydroquinolinyl oxazolidinones
AR040336A1 (en) 2002-06-26 2005-03-30 Glaxo Group Ltd PIPERIDINE COMPOUND, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE SUCH COMPOUND
JP5314244B2 (en) * 2004-10-27 2013-10-16 富山化学工業株式会社 Novel nitrogen-containing heterocyclic compounds and salts thereof
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (en) * 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. Novel nitrogenated heterocyclic compound and salt thereof
KR101409261B1 (en) * 2006-05-26 2014-06-18 다이쇼 세이야꾸 가부시끼가이샤 Novel heterocyclic compound or salt thereof and intermediate thereof
US20100256124A1 (en) * 2006-06-09 2010-10-07 David Thomas Davies Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
NZ573644A (en) * 2006-07-20 2011-09-30 Glaxo Group Ltd Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones

Also Published As

Publication number Publication date
AU2007331247A1 (en) 2008-06-19
EP2121702A1 (en) 2009-11-25
WO2008071961A1 (en) 2008-06-19
KR20090090385A (en) 2009-08-25
CL2007003641A1 (en) 2008-09-22
WO2008071961A8 (en) 2009-10-22
CA2671485A1 (en) 2008-06-19
PE20081511A1 (en) 2008-12-12
TW200831517A (en) 2008-08-01
JP2010513255A (en) 2010-04-30
RU2009126731A (en) 2011-01-20
ECSP099506A (en) 2009-08-28
AU2007331247B2 (en) 2011-10-20
BRPI0720236A2 (en) 2013-12-24
AR064369A1 (en) 2009-04-01
CO6190619A2 (en) 2010-08-19
UY30788A1 (en) 2008-07-31
MX2009006325A (en) 2009-07-24

Similar Documents

Publication Publication Date Title
NO20092476L (en) Antibacterial polycyclic urea compounds
NO20074703L (en) Antibacterial piperidine derivatives
NO20091553L (en) Phenyl derivatives and their use as immunomodulators
NO20083427L (en) Cystotoxic agents comprising novel tomaymycin derivatives and their therapeutic use
NO20091409L (en) Pyridin-3-yl derivatives as immunomodulatory agents
NO20084418L (en) Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
EA201100613A1 (en) CONDENSED, SPYROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
NO20090628L (en) Pyridizinone derivatives
NO20076648L (en) Novel thiophene derivatives
NO20080675L (en) P38-Map kinase inhibitors and methods for their use
EA201001368A1 (en) HETEROCYCLIC UREA DERIVATIVES AND METHODS OF THEIR APPLICATION-211
NO20061657L (en) Pyrol derivatives with antibacterial activity
NO20092655L (en) 2-quinolinone and 2-quinoxalinone derivatives and their use as antibacterial agents
NO20082496L (en) pyrazine derivatives
WO2011158042A3 (en) Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections
NO20074275L (en) 2- (4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
NO20091395L (en) New thiophene derivatives
NO20081315L (en) Benzokinazoline derivatives and their use in the treatment of bone disorders
NO20081942L (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
NO20082159L (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
NO20064201L (en) Glucopyranosyl substituted benzene derivatives, drugs containing such compounds, their use and preparation
NO20083250L (en) Antibacterial pyrrolopyridines, pyrrolopyrimidines and pyrroloazepines
EA201100503A1 (en) GLUCOSIDE DERIVATIVES AND THEIR APPLICATIONS
NO20083708L (en) 4-Phenyl-thiazole-5-carboxylic acid and 4-phenyl-thiazole-5-carboxylmides as PLK1 inhibitors
NO20084363L (en) 2-Substituted 4-benzylphthalazine derivatives as histamine H1 and H3 antagonists

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application